Last reviewed · How we verify

NCT05127252: SweBioFertil

Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive

Recruiting now Last updated 30 May 2023
What this trial tests

trial testing Vaginal and rectal microbiome and metabolome in Pregnancy Complications in 500 participants. Currently enrolling.

Timeline
10 April 2023
Primary endpoint
10 March 2026
30 December 2026

Quick facts

Lead sponsorKarolinska Institutet
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date10 April 2023
Primary completion10 March 2026
Estimated completion30 December 2026
Sites2 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 40, female only, with Pregnancy Complications or Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the microbiome of women with previously proven fertility who plan to become pregnant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pregnancy Complications

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05127252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing